NACC Tribal Health Medication Assisted Recovery (MAR) Services Program
The Native American Community Clinic (NACC) in collaboration with Red Lake Band of
Chippewa Indians propose to expand NACC’s Medication Assisted Treatment (MAT) program
to include a dosing clinic to better address the opioid crisis among Native Americans in the Twin
Cities Metropolitan area through this Minnesota Targeted Capacity Expansion of Medication
Assisted Treatment Services funding. The widespread abuse of prescription drugs and heroin has
resulted in a crisis for Native Americans and tribal communities. Opiate overdoses are a common
occurrence and the disparity between Native Americans and other racial groups continues to
worsen. Suboxone is a medically prescribed and administered treatment for opioid use disorder
(OUD) that has been proven to reduce overdose and promote recovery by suppressing cravings
for illicit drugs. In conjunction with medication, the tribal program model provides
trauma-informed and culturally appropriate behavioral health and psychosocial support. The
project goal is to expand access for Native Americans with OUD to trauma-informed and
culturally appropriate medication-assisted treatment (MAT) in the Twin Cities Metropolitan
area. Implementation Objective 1. Expand medication assisted treatment (MAT) access to
nurse administered Buprenorphine for patients with OUD (as measured by treatment data).
During the ramp up phase, year one, we seek to enroll 40 patients and in year two and three an
additional 60 per year, for an unduplicated patient total of 160. Implementation Objective 2.
Provide trauma-informed and culturally appropriate behavioral health assessment and integrated
care services to patients with OUD. In year one, we seek to engage 20 patients in behavioral
health services, and 30 patients per year in years two and three, for a total of 80 patients.
Implementation Objective 3. Provide access to traditional healing and peer recovery support
services for patients with OUD. In year one, we will seek to enroll 20 patients in services, and an
additional 30 in years two and three, for a total of 80. Outcome Objective 1. Decrease in illicit
opioid drug use at six month follow-up for clients enrolled in the program (individual at intake
and last assessment). Outcome Objective 2. Decrease in the use of prescription opioids in a
non-prescribed manner at six-month follow up for clients enrolled in the program (individual at
intake and last assessment).